Search Home Diomed Developments Dermal Laboratories Diomed OTC Diomed Herbals Aeropak Welcome Products Manufacturing Contacts Aeropak Welcome Welcome In 1998, the Diomed Group acquired Aeropak (Chemical Products) Limited, a contract manufacturer specialising in volatile pharmaceuticals, enabling the group to secure its long-term strategic supply of products from Aeropak. The Aeropak name provides a clue to the Company's origins, more than 30 years ago, as a packer of model aircraft fuel. This highly specialist expertise created a sound base for the logical progression from handling flammable aircraft fuel to handling volatile pharmaceuticals, which became Aeropak's forte. Since its takeover, Aeropak has benefited from an extensive modernisation and investment programme. These efforts culminated in the Company moving, in 2002, to a specially commissioned, state-of-the-art, new manufacturing site in Great Yarmouth. This large, modern factory provides substantially improved facilities to manufacture a greater quantity and variety of pharmaceutical products to the highest applicable standards of GMP. Today, Aeropak produces a great number of NHS medicines for Dermal, as well as OTC products for Diomed Pharmaceuticals & Diomed Herbals. Terms of Use Cookies Job Vacancies Home © 2015 Aeropak (Chemical Products) Ltd

Search Home Diomed Developments Dermal Laboratories Diomed OTC Diomed Herbals Aeropak Welcome Marketing Products R&D Licensing Contacts Diomed OTC Welcome Welcome In the course of the 1990s, the marketing of OTC (over-the-counter) medicines came to represent a major part of the Diomed group's activities. As expansion continued in this area, a separate division became necessary to handle the marketing and licensing of these products. This division was eventually to become Diomed Pharmaceuticals. Diomed Pharmaceuticals has proved to be one of the UK's most outstandingly successful marketeers of OTC medicines. In 1991, it took Ibuleve, the topical painkilling gel, to brand leadership within 3 months of launch. This success was then repeated with Otex Ear Drops in 1995, and with Bazuka, the wart and verruca treatment, in 1996. Both achieved brand leadership in their respective markets within a year of launch. The Freederm range of treatments for spot-prone skin has also achieved a tremendous reception since it hit the market in 2005 and Diomed Pharmaceuticals’ latest OTC, Iglü mouth ulcer treatment - launched in March 2008 - is similarly proving a great success. Diomed Pharmaceuticals is skilled in exporting Diomed's products and know-how to many overseas markets. Diomed also welcomes approaches from companies wishing to out-license both OTC and prescription pharmaceuticals for marketing in the UK and Irish markets. Terms of Use Cookies Job Vacancies Home © 2015 Diomed Pharmaceuticals Ltd